Position in PGEN
as of Mar 31, 2026
· filed Apr 24, 2026
Position Value
$13,903,865
-$1,144,950 QoQ
Shares Held
3,592,730
-0.2% QoQ
Ownership
1.01%
of shares outstanding
% of Portfolio
5.65%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Derivatives in PGEN
reported options exposure · as of Mar 31, 2022CallValue
$168,800
CallShares
80,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026IRIDIAN ASSET MANAGEMENT LLC/CT holds $35,697,443 across 7 Biotechnology names. PGEN ranks #1 (38.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PGEN |
Precigen, Inc.
This page
|
3,592,730 | $13,903,865 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
67,491 | $11,407,328 | |
| 3 | NVCT |
Nuvectis Pharma, Inc.
|
651,757 | $5,038,081 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
75,289 | $2,501,100 | |
| 5 | NKTR |
Nektar Therapeutics
|
31,320 | $2,253,474 | |
| 6 | ELTX |
Elicio Therapeutics, Inc.
|
30,051 | $321,245 | |
| 7 | BCTX |
BriaCell Therapeutics Corp.
|
65,000 | $272,350 |
All Filings in PGEN
Export CSV
34 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,903,865 | 3,592,730 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $15,048,815 | 3,600,195 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $12,064,252 | 3,666,946 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $6,075,700 | 4,278,662 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,832,855 | 4,585,809 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $5,870,952 | 5,241,922 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $3,587,162 | 3,775,960 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $3,269,249 | 2,069,145 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $3,032,347 | 2,091,274 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $2,686,611 | 2,004,934 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $2,951,072 | 2,078,220 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $3,833,488 | 3,333,468 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $3,783,421 | 3,569,266 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $4,377,010 | 2,879,612 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $6,804,996 | 3,209,904 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $5,039,900 | 3,761,120 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $7,605,273 | 3,604,395 | Shares | Sole | 2022-05-02 | |
| 2022-03-31 | $168,800 | 80,000 | Call | Sole | 2022-05-02 | |
| 2021-12-31 | $408,100 | 110,000 | Call | Sole | 2022-02-10 | |
| 2021-12-31 | $13,822,799 | 3,725,822 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $249,500 | 50,000 | Call | Sole | 2021-11-10 | |
| 2021-09-30 | $22,174,137 | 4,443,715 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $46,157,785 | 7,079,415 | Shares | Sole | 2021-08-11 | |
| 2021-06-30 | $326,000 | 50,000 | Call | Sole | 2021-08-11 | |
| 2021-03-31 | $50,654,715 | 7,351,918 | Shares | Sole | 2021-05-11 | |
| 2021-03-31 | $206,700 | 30,000 | Call | Sole | 2021-05-11 | |
| 2020-12-31 | $316,200 | 31,000 | Call | Sole | 2021-02-08 | |
| 2020-12-31 | $4,166,353 | 408,466 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $361,200 | 103,200 | Call | Sole | 2020-11-02 | |
| 2020-09-30 | $1,261,631 | 360,466 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $509,978 | 102,200 | Call | Sole | 2020-08-10 | |
| 2020-06-30 | $1,632,243 | 327,103 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $347,480 | 102,200 | Call | Sole | 2020-05-11 | |
| 2020-03-31 | $1,112,150 | 327,103 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||